Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study

被引：0
|
作者：
Ushma Purohit
Chana A. Sacks
Afsaneh Raissi
Emily Hughes
Monica Boctor
Saba Manzoor
Benazir Hodzic-Santor
Kevin Zhu
Ashley Raudanskis
Joseph S. Ross
Michael Fralick
机构：
[1] Sinai Health System,Division of General Internal Medicine, Department of Medicine
[2] Division of General Internal Medicine,Section of General Internal Medicine and National Clinician Scholars Program
[3] Massachusetts General Hospital,Department of Health Policy and Management
[4] Yale School of Medicine,undefined
[5] Yale University School of Public Health,undefined
来源：
Journal of General Internal Medicine | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3107 / 3114
页数：7
相关论文
共 50 条
  • [1] Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study
    Purohit, Ushma
    Sacks, Chana A.
    Raissi, Afsaneh
    Hughes, Emily
    Boctor, Monica
    Manzoor, Saba
    Hodzic-Santor, Benazir
    Zhu, Kevin
    Raudanskis, Ashley
    Ross, Joseph S.
    Fralick, Michael
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (14) : 3107 - 3114
  • [2] Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study
    Wang, Michael T. M.
    Bolland, Mark J.
    Gamble, Greg
    Grey, Andrew
    PLOS ONE, 2015, 10 (12):
  • [3] Perceived information gain from randomized trials correlates with publication in high-impact factor journals
    Evangelou, Evangelos
    Siontis, Konstantinos C.
    Pfeiffer, Thomas
    Ioannidis, John P. A.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (12) : 1274 - 1281
  • [4] Are acceptance and publication times longer in primary health care journals compared to internal medicine journals? A comparative study of 117 high-impact journals
    Paul Sebo
    Scientometrics, 2023, 128 : 873 - 876
  • [5] Are acceptance and publication times longer in primary health care journals compared to internal medicine journals? A comparative study of 117 high-impact journals
    Sebo, Paul
    SCIENTOMETRICS, 2023, 128 (01) : 873 - 876
  • [6] Role of industry funders in oncology RCTs published in high-impact journals and its association with trial conclusions and time to publication
    Liang, F.
    Zhu, J.
    Mo, M.
    Zhou, C. M.
    Jia, H. X.
    Xie, L.
    Zheng, Y.
    Zhang, S.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2129 - 2134
  • [7] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Allenet, Benoit
    Fraysse, Martial
    Halimi, Jean-Michel
    Grassin, Jacqueline
    Giraudeau, Bruno
    TRIALS, 2014, 15
  • [8] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: study protocol for a randomized controlled trial
    Xavier Pourrat
    Clarisse Roux
    Brigitte Bouzige
    Valérie Garnier
    Armelle Develay
    Benoit Allenet
    Martial Fraysse
    Jean-Michel Halimi
    Jacqueline Grassin
    Bruno Giraudeau
    Trials, 15
  • [9] Impact of drug reconciliation at discharge and communication between hospital and community pharmacists on drug-related problems: a randomized controlled trial
    Pourrat, Xavier
    Roux, Clarisse
    Bouzige, Brigitte
    Garnier, Valerie
    Develay, Armelle
    Fraysse, Martial
    Halimi, Jean-Michel
    Allenet, Benoit
    Giraudeau, Bruno
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 212 - 213
  • [10] Impact of a drug-related patient-reported outcome measure on drug-related problem identification, physicians' acceptance, and clinical and quality of life outcomes: a randomized controlled trial
    Sakthong, Phantipa
    Jaisue, Piyaporn
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (02) : 320 - 329
12345